Literature DB >> 18836704

Effect of intranasally administered cholecystokinin on encoding of controlled and automatic memory processes.

Ronald Schneider1, Judith Osterburg, Axel Buchner, Reinhard Pietrowsky.   

Abstract

RATIONALE: The neuropeptide cholecystokinin (CCK) is present in abundance in the central nervous system, where it is involved in the regulation of a wide range of functions. It also takes part in the modulation of memory processes, but its effect on human memory systems and processes is not yet well understood.
OBJECTIVE: The present experiment was conducted to examine the influence of CCK when present during encoding on later controlled and automatic recognition memory processes in humans.
MATERIALS AND METHODS: A version of the process dissociation procedure was used to separate the contributions of controlled and automatic memory processes to participants' recognition memory performance. Data were analyzed within a multinomial modeling framework. Participants (N = 64) received either 40 microg CCK-8S or placebo intranasally. The learning and test phases began 30 min after substance application. Behavioral, physiological, and self-report control variables were measured at three points of time during the experiment.
RESULTS: Compared to placebo, CCK increased the automatic, familiarity-based recognition memory component, while the parameter representing controlled, retrieval-based processes did not differ between groups. Also, in the exclusion condition of the test phase, the guessing parameter was reduced by CCK. None of the control variables were affected by the peptide.
CONCLUSIONS: This result-the enhancement of the automatic recognition memory component when CCK is applied before encoding (and thus present during encoding and retrieval)-complements earlier results indicating that CCK decreases controlled, recollection-based recognition memory when applied during consolidation. The possible neuronal systems and processes mediating these effects are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836704     DOI: 10.1007/s00213-008-1332-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

Review 1.  Memory--a century of consolidation.

Authors:  J L McGaugh
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

2.  Theoretical and empirical review of multinomial process tree modeling.

Authors:  W H Batchelder; D M Riefer
Journal:  Psychon Bull Rev       Date:  1999-03

Review 3.  Neuropeptides in perspective: the last ten years.

Authors:  T Hökfelt
Journal:  Neuron       Date:  1991-12       Impact factor: 17.173

4.  Invariance in automatic influences of memory: toward a user's guide for the process-dissociation procedure.

Authors:  L L Jacoby
Journal:  J Exp Psychol Learn Mem Cogn       Date:  1998-01       Impact factor: 3.051

Review 5.  Episodic memory, amnesia, and the hippocampal-anterior thalamic axis.

Authors:  J P Aggleton; M W Brown
Journal:  Behav Brain Sci       Date:  1999-06       Impact factor: 12.579

6.  Intranasally administered Cholecystokinin decreases controlled memory.

Authors:  Ronald Schneider; Carmen Stöhr; Reinhard Pietrowsky
Journal:  Biol Psychol       Date:  2004-12-02       Impact factor: 3.251

7.  Toward unbiased measurement of conscious and unconscious memory processes within the process dissociation framework.

Authors:  Axel Buchner; Edgar Erdfelder; Bianca Vaterrodt-Plünnecke
Journal:  J Exp Psychol Gen       Date:  1995-06

8.  CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.

Authors:  M Lemaire; G A Böhme; O Piot; B P Roques; J C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

9.  Cholecystokinin-induced effects on selective attention depend on level of activation.

Authors:  R Pietrowsky; S Rudolf; M Mölle; H L Fehm; J Born
Journal:  Neuropsychobiology       Date:  1997       Impact factor: 2.328

Review 10.  Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.

Authors:  Susan Rotzinger; Franco J Vaccarino
Journal:  J Psychiatry Neurosci       Date:  2003-05       Impact factor: 6.186

View more
  6 in total

1.  Intranasal application of secretin, similarly to intracerebroventricular administration, influences the motor behavior of mice probably through specific receptors.

Authors:  Andrea Heinzlmann; Gusztáv Kiss; Zsuzsanna E Tóth; Roberta Dochnal; Ágnes Pál; Ildikó Sipos; Máté Manczinger; Gyula Szabó; Hitoshi Hashimoto; Katalin Köves
Journal:  J Mol Neurosci       Date:  2012-07-01       Impact factor: 3.444

2.  Bi-directional effect of cholecystokinin receptor-2 overexpression on stress-triggered fear memory and anxiety in the mouse.

Authors:  Qian Chen; Mingxi Tang; Takayoshi Mamiya; Heh-In Im; Xiaoli Xiong; Anu Joseph; Ya-Ping Tang
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

3.  Effect of cholecystokinin on learning and memory, neuronal proliferation and apoptosis in the rat hippocampus.

Authors:  Parham Reisi; Ali Reza Ghaedamini; Mohammad Golbidi; Moloud Shabrang; Zohreh Arabpoor; Bahman Rashidi
Journal:  Adv Biomed Res       Date:  2015-10-07

4.  Acute effect of cholecystokinin on short-term synaptic plasticity in the rat hippocampus.

Authors:  L Kamali Dolatabadi; P Reisi
Journal:  Res Pharm Sci       Date:  2014 Sep-Oct

5.  Non-Invasive Strategies for Nose-to-Brain Drug Delivery.

Authors:  J T Trevino; R C Quispe; F Khan; V Novak
Journal:  J Clin Trials       Date:  2020-12-10

6.  Cholecystokinin octapeptide improves hippocampal glutamatergic synaptogenesis and postoperative cognition by inhibiting induction of A1 reactive astrocytes in aged mice.

Authors:  Lei Chen; Ning Yang; Yue Li; Yitong Li; Jingshu Hong; Qian Wang; Kaixi Liu; Dengyang Han; Yongzheng Han; Xinning Mi; Chengmei Shi; Ying Zhou; Zhengqian Li; Taotao Liu; Xiangyang Guo
Journal:  CNS Neurosci Ther       Date:  2021-08-17       Impact factor: 5.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.